(PI-013) The introduction of Fentonite and Octenidine based products into non-healing wounds of patients with DM and Vascular Insufficiency.

michelle moore, MSN RN CWCN

Introduction: Non-healing wounds create a significant burden on patients, the healthcare system and the clinician.  Various dressing incorporates silver and other antimicrobials with various degrees of success.  A new innovative product line introduces Fentonite and Octenidine which dissolves biofilm, reduces the bioburden and stimulates the wound to heal.   Fentonite sequesters the chloride found in exudate, allowing the silver to remain active in elimination the bioburden in the wound bed.  In these case studies, we show the exciting effectiveness of this new wound care product line.  The Fentonite, Octenidine and Silver Nanoparticles allowed for movement and closure of non-healing wounds by reducing the bioburden and the biofilm formation. Incorporating new technology into wound care practice can aid in the healing processes that have stalled out.  The purpose of the study was to evaluate the new technology on a patient with numerous non-healing wounds.

Methods: Pt. had non-healing wounds for over six years with failed grafts, numerous prior products use and wounds remained a clinical challenge.  We trialed the new technology of Fentonite and Octenidine in both a gel format and a liquid cleansing format.  Dressing were changed 3 times a week in clinic.

Results: After 3 months of treatment, we had 2 wounds with full granulation tissue and one completely healed out.  The total cost of the product would have been $300 for the 3 months of treatment. The patient showed response within the first 2 weeks of utilization, Pt also stated a decrease in pain and social detachment.

Discussion: The use of Fentonite and Octenidine products in non-healing wounds showed a high level of promise. In bringing new innovation to the healthcare industry and the willingness to try new products when healing stalled should be evaluated when appropriate.  Continued studies need to be conducted to increase the success rate of non-healing wounds.

Trademarked Items: Bioclense, Biorelese and AgFresh

References: